Abstract
The uptake of quinolone antibiotics by Escherichia coli was investigated by using fleroxacin (RO 23-6240, AM 833) as a prototype compound. The uptake of fleroxacin was reduced and its MIC was increased in the presence of magnesium. Quinolones induced lipopolysaccharide release, increased cell-surface hydrophobicity and outer membrane permeability to B-lactams, and sensitized cells to lysis by detergents. These effects were also antagonized by magnesium and were very similar to those seen with EDTA and gentamicin. MICs of quinolones in portin-deficient strains were increased relative to those of the parent strain, consistent with a porin pathway of entry. However, MICs were further increased in the presence of magnesium; the size of the additional increase showed a positive correlation with quinolone hydrophobicity in an OmpF- OmpC- OmpA- strain. When quinolones were mixed with divalent cations in solution, changes in quinolone fluorescence suggestive of metal chelation were observed. The addition of fleroxacin to a cell suspension resulted in a rapid initial association of fluorescence with cells, followed by a brief decrease and a final time-dependent linear increase in cell-associated fluorescence. We interpret these results as representing chelation of outer membrane-bound magnesium by fleroxacin and other quinolones, dissociation of the quinolone-magnesium complex from the outer membrane, and diffusion of the quinolone through both porins and exposed lipid domains on the outer membrane. For a given quinolone, the contribution of the porin and nonporin pathways to total uptake is influenced by the hydrophobicity of the quinolone.
MeSH Terms
Aminoglycosides
Anti-Bacterial Agents/metabolism,pharmacology
Cell Membrane Permeability/drug effects
Ciprofloxacin/analogs & derivatives,metabolism
Escherichia coli/metabolism
Fleroxacin
Magnesium/pharmacology
Magnesium Chloride
Quinolines/metabolism
Spectrometry, Fluorescence
Chemicals
Aminoglycosides
Anti-Bacterial Agents
Quinolines
Magnesium Chloride
Ciprofloxacin
Magnesium
Fleroxacin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Chapman J S
Roche Research Center, Nutley, New Jersey 07110.
Georgopapadakou N H
References (25)
25 references, click to expand
-
Effect of EDTA upon bacterial permeability to benzylpenicillin.
Biochem Biophys Res Commun. 1965 Sep 22;20(6):688-91
PMID: 4955536
-
Accumulation of enoxacin by Escherichia coli and Bacillus subtilis.
Antimicrob Agents Chemother. 1987 Sep;31(9):1348-54
PMID: 2823695
-
Aggregation formation in three species of planaria: distance to nearest neighbour.
Nature. 1967 May 27;214(5091):895-6
PMID: 6054973
-
Rapid fixed-time assay for penicillinase.
J Bacteriol. 1968 Apr;95(4):1493-4
PMID: 5646633
-
Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate.
J Biol Chem. 1968 May 10;243(9):2373-80
PMID: 4967584
-
Properties of a R factor which originated in Pseudomonas aeruginosa 1822.
J Bacteriol. 1972 May;110(2):529-37
PMID: 4336689
-
Characterization of Escherichia coli mutant incapable of maintaining a transmembrane potential. MetC ecfts mutations.
J Biol Chem. 1977 Jun 25;252(12):4056-67
PMID: 16923
-
DNA topoisomerases.
Annu Rev Biochem. 1981;50:879-910
PMID: 6267993
-
Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1981 May;19(5):777-85
PMID: 6794444
-
Porin channels in Escherichia coli: studies with beta-lactams in intact cells.
J Bacteriol. 1983 Jan;153(1):232-40
PMID: 6294048
-
Role of porin proteins OmpF and OmpC in the permeation of beta-lactams.
Antimicrob Agents Chemother. 1982 Dec;22(6):942-8
PMID: 6760806
-
Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide.
Nature. 1983 Jun 9-15;303(5917):526-8
PMID: 6406904
-
Alterations in outer membrane permeability.
Annu Rev Microbiol. 1984;38:237-64
PMID: 6093683
-
Difference in pathway of Escherichia coli outer membrane permeation between penicillins and cephalosporins.
FEBS Lett. 1985 Feb 11;181(1):143-8
PMID: 3882453
-
Measurement of ionized calcium in blood platelets with a new generation calcium indicator.
Biochem Biophys Res Commun. 1985 Oct 30;132(2):652-7
PMID: 3840688
-
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
Antimicrob Agents Chemother. 1986 Apr;29(4):639-44
PMID: 3010850
-
Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
Antimicrob Agents Chemother. 1986 Mar;29(3):535-8
PMID: 3521490
-
Gentamicin interaction with Pseudomonas aeruginosa cell envelope.
Antimicrob Agents Chemother. 1986 Jun;29(6):1079-87
PMID: 2425732
-
Shielding of Escherichia coli outer membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains of lipopolysaccharide.
J Bacteriol. 1986 Oct;168(1):449-51
PMID: 2428812
-
Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
Antimicrob Agents Chemother. 1986 Aug;30(2):248-53
PMID: 3532944
-
Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo.
J Bacteriol. 1987 Feb;169(2):856-63
PMID: 2433267
-
Release of endotoxin from Escherichia coli by quinolones.
J Antimicrob Chemother. 1986 Dec;18(6):765-6
PMID: 3546245
-
Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
Antimicrob Agents Chemother. 1987 Feb;31(2):161-3
PMID: 3105446
-
Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae.
Antimicrob Agents Chemother. 1987 May;31(5):758-62
PMID: 3300538
-
Release of lipopolysaccharide by EDTA treatment of E. coli.
Biochem Biophys Res Commun. 1965 Nov 22;21(4):290-6
PMID: 4159978